VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
VERAXA Biotech AG (Nasdaq: VRXA) has appointed Raju Willener as its new Chief Financial Officer. Mr. Willener brings over three decades of experience in financial leadership, including a prior role as Director of Corporate Development at Exentis Group AG and later serving as CFO there starting in 2025. Christoph Antz, Ph.D., CEO and co-founder of VERAXA Biotech, highlighted that Mr. Willener's expertise will be instrumental in advancing the company’s capital strategy, evaluating strategic opportunities, and supporting long-term shareholder value creation as it develops its proprietary BiTAC technology platform and oncology pipeline. The appointment reflects a strategic move to strengthen financial leadership during an important phase of growth for VERAXA.
Tickers: $VRXA
Topics: Biotech CFO Leadership Change